" In 2024, Elis delivered record revenue close to €4.6bn, up +6.1% compared to 2023. Organic revenue growth was up +5.2%, with +5.0% in Q4, showing sequential improvement compared to the two previous ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...